coumarin has been researched along with Recrudescence in 16 studies
2H-chromen-2-one: coumarin derivative
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the effect of long-term anticoagulant treatment (enoxaparin vs coumarin) in patients with deep venous thrombosis (DVT) as to incidence of post-thrombotic syndrome (PTS) and recurrent venous thromboembolism." | 9.13 | Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. ( Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C, 2008) |
| " with coumarin) is still the most widely used treatment for deep venous thromboembolism." | 9.07 | Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. ( del Rio, L; Lafoz, E; Monreal, M; Olive, A; Vedia, C, 1994) |
| "Defiency of protein C has been reported to be associated with recurrent thrombosis and pulmonary embolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis and peripheral gangrene." | 7.67 | Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency. ( Lie, JT, 1988) |
| "Colitis was induced in rat by instillation of trinitrobenzenesulphonic acid (TNBS)." | 5.38 | Suppression of TNBS-induced colitis in rats by 4-methylesculetin, a natural coumarin: comparison with prednisolone and sulphasalazine. ( Di Stasi, LC; Felisbino, SL; Gálvez, J; Garrido-Mesa, N; Hiruma-Lima, CA; Luchini, AC; Utrilla, P; Witaicenis, A, 2012) |
| "Patients with thrombolysis in myocardial infarction (TIMI) 3 flow <48 hours after fibrinolysis for ST-elevation myocardial infarction were randomized to aspirin plus coumarin, with prolonged heparinization until the target international normalized ratio (2-3) was reached, or aspirin with standard heparinization." | 5.14 | Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. ( Aengevaeren, WR; Brouwer, MA; Kievit, PC; van den Bergh, PJ; Veen, G; Verheugt, FW, 2009) |
| "We evaluated the effect of long-term anticoagulant treatment (enoxaparin vs coumarin) in patients with deep venous thrombosis (DVT) as to incidence of post-thrombotic syndrome (PTS) and recurrent venous thromboembolism." | 5.13 | Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. ( Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C, 2008) |
| " with coumarin) is still the most widely used treatment for deep venous thromboembolism." | 5.07 | Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. ( del Rio, L; Lafoz, E; Monreal, M; Olive, A; Vedia, C, 1994) |
| " Coumarin-induced skin necrosis was a recurrent feature during oral anticoagulation therapy, forcing her physicians to treat her with nadroparin (Fraxiparin) for only a few months." | 3.72 | Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency. ( Alhenc-Gelas, M; Corazza, F; Demulder, A; Ferster, A; Loop, M, 2004) |
| "Defiency of protein C has been reported to be associated with recurrent thrombosis and pulmonary embolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis and peripheral gangrene." | 3.67 | Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency. ( Lie, JT, 1988) |
| "Eighteen patients with vitiligo were treated with two crystalline substances, xanthotoxin (Ammoidin) and imperatorin (Ammidin) from the plant Ammi majus." | 3.63 | Ammoidin (xanthotoxin) in the treatment of vitiligo. ( COUPERUS, M, 1954) |
| "Once- or twice-daily subcutaneous dosing of LMWHs without laboratory monitoring has facilitated outpatient VTE therapy." | 2.42 | Outpatient treatment of acute venous thromboembolic disease. ( Gage, BF; Yusen, RD, 2003) |
| "Colitis was induced in rat by instillation of trinitrobenzenesulphonic acid (TNBS)." | 1.38 | Suppression of TNBS-induced colitis in rats by 4-methylesculetin, a natural coumarin: comparison with prednisolone and sulphasalazine. ( Di Stasi, LC; Felisbino, SL; Gálvez, J; Garrido-Mesa, N; Hiruma-Lima, CA; Luchini, AC; Utrilla, P; Witaicenis, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Köckerling, F | 1 |
| Roessing, C | 1 |
| Adolf, D | 1 |
| Schug-Pass, C | 1 |
| Jacob, D | 1 |
| González-Fajardo, JA | 1 |
| Martin-Pedrosa, M | 1 |
| Castrodeza, J | 1 |
| Tamames, S | 1 |
| Vaquero-Puerta, C | 1 |
| van den Bergh, PJ | 1 |
| Kievit, PC | 1 |
| Brouwer, MA | 1 |
| Aengevaeren, WR | 1 |
| Veen, G | 1 |
| Verheugt, FW | 1 |
| THORSEN, G | 1 |
| Witaicenis, A | 1 |
| Luchini, AC | 1 |
| Hiruma-Lima, CA | 1 |
| Felisbino, SL | 1 |
| Garrido-Mesa, N | 1 |
| Utrilla, P | 1 |
| Gálvez, J | 1 |
| Di Stasi, LC | 1 |
| Yusen, RD | 1 |
| Gage, BF | 1 |
| COUPERUS, M | 1 |
| Loop, M | 1 |
| Ferster, A | 1 |
| Corazza, F | 1 |
| Alhenc-Gelas, M | 1 |
| Demulder, A | 1 |
| Lobo, JL | 1 |
| Jiménez, D | 1 |
| Teresa Orue, M | 1 |
| Grau, E | 1 |
| Naufall, D | 1 |
| Madridano, O | 1 |
| Monreal, M | 2 |
| Lafoz, E | 1 |
| Olive, A | 1 |
| del Rio, L | 1 |
| Vedia, C | 1 |
| Bauer, KA | 1 |
| Franke, A | 1 |
| van Oppen, J | 1 |
| van Ommen, V | 1 |
| Bär, FW | 1 |
| de Swart, JB | 1 |
| van der Veen, FH | 1 |
| Wellens, HJ | 1 |
| Wankmüller, H | 1 |
| Ellbrück, D | 1 |
| Seifried, E | 1 |
| Weiss, T | 1 |
| Diehm, C | 1 |
| Müller-Bühl, U | 1 |
| Schiffl, R | 1 |
| Wilhelm, C | 1 |
| Richter, GM | 1 |
| Lie, JT | 1 |
3 reviews available for coumarin and Recrudescence
| Article | Year |
|---|---|
Outpatient treatment of acute venous thromboembolic disease.
Topics: Acute Disease; Ambulatory Care; Anticoagulants; Coumarins; Fibrinolytic Agents; Heparin; Heparin, Lo | 2003 |
Management of patients with hereditary defects predisposing to thrombosis including pregnant women.
Topics: Abnormalities, Drug-Induced; Anticoagulants; Antithrombin III; Antithrombin III Deficiency; Blood Pr | 1995 |
[The pathophysiology, clinical picture and treatment of coumarin-induced necrosis].
Topics: Administration, Oral; Coumarins; Humans; Incidence; Necrosis; Recurrence; Risk Factors; Skin Disease | 1991 |
3 trials available for coumarin and Recrudescence
| Article | Year |
|---|---|
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
Topics: Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Ag | 2008 |
Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
Topics: Aged; Anticoagulants; Aspirin; Coronary Occlusion; Coumarins; Hemorrhage; Humans; International Norm | 2009 |
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Topics: Adult; Aged; Aged, 80 and over; Contraindications; Coumarins; Dalteparin; Female; Fractures, Spontan | 1994 |
10 other studies available for coumarin and Recrudescence
| Article | Year |
|---|---|
Has endoscopic (TEP, TAPP) or open inguinal hernia repair a higher risk of bleeding in patients with coagulopathy or antithrombotic therapy? Data from the Herniamed Registry.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Austria; Blood Coagulation Disorders; Comorbidity; C | 2016 |
Dicoumarol poisoning with relapse: report of a case.
Topics: Aged; Chronic Disease; Coumarins; Dicumarol; Humans; Recurrence | 1947 |
Suppression of TNBS-induced colitis in rats by 4-methylesculetin, a natural coumarin: comparison with prednisolone and sulphasalazine.
Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Colitis; Coumarins; C | 2012 |
Ammoidin (xanthotoxin) in the treatment of vitiligo.
Topics: Adult; Ammi; Coumarins; Dermatitis; Female; Furocoumarins; Humans; Methoxsalen; Recurrence; Research | 1954 |
Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency.
Topics: Age of Onset; Anticoagulants; Child; Coumarins; DNA Mutational Analysis; Ecchymosis; Family Health; | 2004 |
Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism.
Topics: Aged; Coumarins; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Recurrence; Registries; Veno | 2007 |
[Prevention of embolism in atrial septal defects?].
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Coumarins; Embolism; Female; Fibrinolytic Agents; Heart | 2000 |
Complications after intracoronary stent implantation: three cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Di | 1992 |
[Thrombosis of the inferior vena cava in a 20-year-old patient with decreased protein C activity].
Topics: Adult; Coumarins; Female; Heparin; Humans; Phlebography; Protein C; Protein C Deficiency; Recurrence | 1990 |
Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency.
Topics: Adolescent; Blood Coagulation; Coumarins; Disseminated Intravascular Coagulation; Female; Gangrene; | 1988 |